Rahbar A, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B
affected people may use fewer (or no) substances and not agonize over it
But neither of those makes WeightWatchers the default for daily GLP-1 tracking
Till exempel ldre, hemlsa eller funktionshindrade som kanske inte kan anvnda appar eller inte har ett eget konto
2) Engagement is linked to longer medication program persistence and stronger renewal In a separate January 2026 analysis focused on persistence, members in the top quartile of engagement were, on average, on a GLP-1 medication program for over twice as long (2.2x) within the first 12 months as those in the bottom quartile
Participants taking GLP-1s were also 19% less likely to die from any cause during nearly 40 months of follow-up